A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer.

被引：0
|
作者：
Seiwert, TY
Connell, PP
Mauer, AM
Hoffman, PC
George, CM
Szeto, L
Obasaju, C
Haraf, DJ
Salgia, R
Vokes, EE
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：635S / 635S
页数：1
相关论文
共 50 条
  • [41] Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase I Study
    Zhou, Rui
    Liu, Fangjie
    Zhang, Hongmei
    Wang, Daquan
    Zhang, Pengxin
    Zheng, Shiyang
    Liu, Yimei
    Chen, Li
    Guo, Jinyu
    Zou, Yingyi
    Rong, Yu-Ming
    Liu, Hui
    Qiu, Bo
    CLINICAL CANCER RESEARCH, 2024, 30 (13) : 2719 - 2728
  • [42] Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancer
    Takemoto, Shinnosuke
    Nakamura, Yoichi
    Fukuda, Minoru
    Senju, Hiroaki
    Gyotoku, Hiroshi
    Taniguchi, Hirokazu
    Shimada, Midori
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Hayashi, Nobuyuki
    Soda, Hiroshi
    Mukae, Hiroshi
    THORACIC CANCER, 2017, 8 (06) : 577 - 581
  • [43] Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial
    Koukourakis, MI
    Kourousis, C
    Kamilaki, M
    Koukouraki, S
    Giatromanolaki, A
    Kakolyris, S
    Kotsakis, A
    Androulakis, N
    Bahlitzanakis, N
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) : 838 - 844
  • [44] Impact of prior ALK-tyrosine kinase inhibitor on pemetrexed-based chemotherapy in patients with advanced ALK positive non-small cell lung cancer.
    Yabe, Michitoshi
    Kenmotsu, Hirotsugu
    Kodama, Hiroaki
    Nishioka, Naoya
    Miyawaki, Eriko
    Miyawaki, Taichi
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer
    Arrieta, Oscar
    Blake, Monika
    Dolores de la Mata-Moya, Maria
    Corona, Francisco
    Turcott, Jenny
    Orta, David
    Alexander-Alatorre, Jorge
    Gallardo-Rincon, Dolores
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 (02) : 311 - 315
  • [46] Association between different EGFR mutation status and survival in pemetrexed-based chemotherapy for advanced non-small cell lung cancer
    郏博
    ChinaMedicalAbstracts(InternalMedicine), 2014, 31 (01) : 34 - 35
  • [47] Weekly paclitaxel and carboplatin chemotherapy with concomitant radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC)
    Spasova, Irena
    Pajdhauser, Roman
    Skacel, Zdenek
    Marel, Miloslav
    Musil, Jaromir
    CHEST, 2006, 130 (04) : 233S - 233S
  • [48] Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer
    Dudek, Arkadiusz Z.
    Larson, Timothy
    McCleod, Michael J.
    Schneider, Daniel J.
    Dowell, Jonathan E.
    Banerjee, Tarit K.
    Pandya, Kishan J.
    Bromund, Jane L.
    Chen, Ruqin
    Monberg, Matthew J.
    Obasaju, Coleman K.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 394 - 399
  • [49] Definitive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Dose and Fractionation
    Dagoglu, Nergiz
    Karaman, Sule
    Arifoglu, Alptekin
    Kucucuk, Seden
    Oral, Ethem N.
    BALKAN MEDICAL JOURNAL, 2014, 31 (04) : 278 - 285
  • [50] Phase I dose-escalating study of bi-weekly pemetrexed (MTA) with fixed dose rate gemcitabine (gem) in patients with advanced cancer.
    Chen, A. L.
    Ryan, T.
    Muggia, F.
    Chachoua, A.
    Escalon, J.
    Moore, S.
    Haniff, F.
    Levinson, B.
    Nicol, S.
    Hochster, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 91S - 91S
12345